HA-HCP
DevicePrescription hearing aid fit by a hearing healthcare professional using audiology best practices.
NCT Number: NCT06689865
The research will explore outcomes of different service delivery models of over-the-counter (OTC) hearing aids by comparing them to prescription hearing aids fitted by specialists in individuals with mild to moderate hearing loss. The investigators will examine how each type affects users' experiences, behavior, thinking skills, and brain activity related to hearing. Additionally, the study will focus on what types of people prefer each hearing aid option, what helps or hinders these choices, and compare the costs of four different service options. This approach will help transition from research findings into real-world practice, providing useful information for healthcare providers and policymakers about OTC hearing aid options.
Interested in participating?
Request Info40 year and older
All sexes
Interventional
Not applicable
University of Colorado School of Medicine, Aurora, Colorado, United States
The aim of the proposed project is to evaluate the effectiveness of emerging over-the-counter (OTC) service delivery models with the gold standard traditional prescription hearing aids fit by hearing care professionals (HCP) using audiology best practices. OTC service delivery models include OTC HA fit to individual users using best practices with in person HCP support (OTC-HPC), via remote consultation (OTC-R) and self-fit OTC HAs without any clinical support (OTC-SF). The study will use a prospective four-arm randomized controlled trial design with longitudinal repeated measures.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Prescription hearing aid fit by a hearing healthcare professional using audiology best practices.
Over-the-counter hearing aids fit by a hearing care professional using audiology best practices.
OTC fit to an individual using some best practices via remote consultation.
Self-fit OTC hearing aids without any clinical support from HCPs.
Time frame: T0 = Baseline, T1 = 6 months post intervention, T2 = 12 months post intervention
It is a 24-item self-reported measure of hearing disability and hearing aid benefit. It includes four subscales that address different listening challenges: ease of communication, reverberation, background noise, and aversiveness of sounds, with each subscales comprising six items. The ease of communication, reverberation, and background noise primarily measure challenges related to speech communication. The global score on the APHAB is the average of these three subscale scores. The hearing aid benefit is calculated by comparing the difficulty level reported without amplification (unaided) to the difficulty level with amplification (aided). Scores range from 1% to 99%, with higher scores indicating greater perceived hearing difficulty.
Time frame: T0= Baseline, T1= 6 months post intervention, T2= 12 months post intervention
SADL is a 15-item self-reported outcome measure that evaluates an individual's satisfaction with their hearing aids on a 7-point rating scale. The questionnaire is divided into four subscales. The positive effect subscale quantifies improved performance with hearing aids. The personal image subscale quantifies self-image and stigma. The negative feature subscale evaluates undesirable aspects of using hearing aids. The service and cost subscale assesses the adequacy of the professional's service and the device's cost. Higher scores indicate greater satisfaction with hearing aids.
Time frame: T0= Baseline, T1= 6 months post intervention, T2= 12 months post intervention
It is a 10-item self-perceived hearing handicap measure that can be used for adults of all ages. The response options on this scale are yes (4), sometimes (2), and no (0), and ranges from 0 to 40. The total score is the sum of all the responses, with higher scales indicating greater perceived difficulties.
Time frame: T1= 6 months post intervention, T2= 12 months post intervention
PGI-C assesses the patient's belief about the efficacy of treatment with a single-item questionnaire on a 7-point rating scale. Lower scores indicate improved outcomes.
Time frame: T0= Baseline, T1= 6 months post intervention, T2= 12 months post intervention
The connected speech test is a sentence intelligibility test consisting of 48 passages with 8-10 sentences of a connected discourse spoken by a female speaker. A pair of passages will be presented to the participant, and the 25 keywords in each passage will be scored for percentage correct score. A higher percentage correct score indicates higher sentence intelligibility.
Time frame: T0= Baseline, T1= 6 months post intervention, T2= 12 months post intervention
It assesses the patient's ability to hear in background noise. The patient repeats sentences that are embedded in different noisy environments and the result is a signal-to-noise ratio loss. The test stimuli are pre-recorded sentences embedded in speech babble at varying signal-to-noise ratios from easy to very difficult.
Contact information is provided by the study sponsor or research team.
Preeti Pandey, PhD
CONTACT
Research Service Professional
CONTACT
University of Colorado, Denver
Other
Effectiveness Trial to Examine the Emerging Service Delivery Models for Over-the-Counter (OTC) Hearing Aids
Acronym: IHAT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04618315
Ear Diseases, Hearing Aids
Chicago, Illinois, United States
View Trial DetailsNCT04501081
Ear Diseases, Hearing Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT07690670
Ear Diseases, Hearing Disorders
Pretoria, Province, South Africa
View Trial DetailsNCT06375278
Cochlear Implantation, Cochlear Implants
Miami, Florida, United States
View Trial Details